Scoop has an Ethical Paywall
Scoop InfoPages
This InfoPage in unregistered, if this is your news page register PHARMAC for InfoPages here.
PHARMAC - Latest News [Page 13]
PHARMAC Acknowledges The Work Of Pharmacists
Thursday, 24 September 2020, 10:08 am | PHARMAC
As millions of pharmacists celebrate the 10th anniversary of World Pharmacists Day tomorrow, PHARMAC’s Chief Executive Sarah Fitt acknowledges the extraordinary work done by New Zealand pharmacists and pharmacy staff this year. “It feels appropriate ... More >>
PHARMAC Seeking Views On Widened Access To Juvenile Idiopathic Arthritis Medicines
Friday, 11 September 2020, 9:08 am | PHARMAC
PHARMAC is looking at widening access to three funded treatments – adalimumab, etanercept and tocilizumab – to enable more young people with juvenile idiopathic arthritis to benefit from these medicines. Juvenile idiopathic arthritis (JIA) is ... More >>
PHARMAC Seeking Views On New Type 2 Diabetes Medicines
Wednesday, 9 September 2020, 12:07 pm | PHARMAC
PHARMAC is looking at funding two new oral medicines with substantial health benefits for the 50,000 New Zealanders with type 2 diabetes. The medicines are empagliflozin (brand name Jardiance), empagliflozin with metformin (brand name Jardiamet), and ... More >>
Oral Contraceptive In Short Supply
Thursday, 6 August 2020, 1:17 pm | PHARMAC
PHARMAC has today advised healthcare professionals that a combined oral contraceptive, Brevinor-1 28 Day, is in short supply due to manufacturing delays. Brevinor-1 28 Day (ethinyloestradiol 35 mcg with norethisterone 1 mg) is a funded combined oral ... More >>
PHARMAC Considering A New Way Of Contracting For Medicines
Tuesday, 4 August 2020, 12:22 pm | PHARMAC
Consultation has gone out today to health professionals and is available on PHARMAC’s website for anyone wanting to have their say about our annual tender process and a proposal to modify our contracting arrangements. Every year PHARMAC invites tenders ... More >>
Paracetamol 500mg Tablets In Short Supply At Pharmacies
Friday, 17 July 2020, 5:05 pm | PHARMAC
PHARMAC has today updated healthcare professionals that paracetamol 500mg tablets for dispensing in pharmacies are in short supply due to global supply issues caused by COVID-19, and work is underway to secure more stock. “COVID-19 is impacting ... More >>
PHARMAC To Remove Medicine Dispensing Restrictions
Thursday, 9 July 2020, 9:39 am | PHARMAC
Most funded medicines will return to all at once dispensing because PHARMAC is removing most of the temporary dispensing restrictions put in place to manage supply during COVID-19. The change will be effective from midnight Friday 31 July 2020. “This ... More >>
Independent Review Of Lamotrigine Sole Supply Decision By PHARMAC
Friday, 5 June 2020, 10:11 am | PHARMAC
An independent review on the lamotrigine sole-supply decision has found that PHARMAC’s processes were evidence based and robust, and of a high standard. The review was published on the PHARMAC website today and shared with people who had been engaging ... More >>
PHARMAC To Fund New Cystic Fibrosis Medicine
Saturday, 30 May 2020, 8:35 am | PHARMAC
From Monday a new medicine is being funded by PHARMAC which will help young children with cystic fibrosis digest their food more easily. Creon Micro, supplied by Mylan, is a modified-release granule formulation of pancreatic enzymes. It enables smaller ... More >>
PHARMAC Places Temporary Dispensing Limits On All Funded Community Medicines
Thursday, 26 March 2020, 1:30 pm | PHARMAC
PHARMAC is placing temporary dispensing limits on all funded community medicines from Friday 27 March 2020. Changes will be made to the Pharmaceutical Schedule, which is a list of the prescription medicines and therapeutic products subsidised by the ... More >>
PHARMAC Funds New Medicine (mepolizumab) For Severe Asthma
Thursday, 12 March 2020, 12:42 pm | PHARMAC
Around 500 New Zealanders who have severe asthma will have access to a new medicine, mepolizumab, from next month. Severe asthma sufferers who use mepolizumab are less likely to end up in hospital and less likely to experience their symptoms getting ... More >>
PHARMAC seeking views on new cystic fibrosis medicine
Friday, 24 January 2020, 1:01 pm | PHARMAC
PHARMAC has reached a provisional agreement with medicine supplier Vertex to fund ivacaftor (marketed as Kalydeco) for people with cystic fibrosis. More >>
PHARMAC considering new medicines for type 2 diabetes
Wednesday, 15 January 2020, 4:44 pm | PHARMAC
PHARMAC is seeking proposals from pharmaceutical suppliers for new medicines that could help New Zealanders living with type 2 diabetes. More >>
PHARMAC seeking views on new breast cancer medicine
Wednesday, 15 January 2020, 10:01 am | PHARMAC
PHARMAC has reached a provisional agreement with medicine supplier Pfizer to fund palbociclib (marketed as Ibrance) for first-line and second-line treatment of certain types of breast cancer. More >>
Spinraza funding application reviewed
Tuesday, 17 December 2019, 9:28 am | PHARMAC
PHARMAC has published the Rare Disorders Subcommittee meeting records which recommends Spinraza (nusinersen), a medication for spinal muscular atrophy, is funded in New Zealand. More >>
PHARMAC to fund more cancer medicines and faster assessment
Thursday, 5 December 2019, 9:09 am | PHARMAC
Thousands of New Zealanders with lymphoma, breast, ovarian and blood cancers will have more treatment options available to them in the New Year. More >>
PHARMAC widening access to the meningococcal ACWY vaccine
Thursday, 14 November 2019, 9:38 am | PHARMAC
The meningococcal ACWY vaccine will be available free from next month for young people in close living situations. More >>
PHARMAC funding new leukaemia medicine
Monday, 4 November 2019, 10:19 am | PHARMAC
New Zealanders with chronic lymphocytic leukaemia will have another medicine option available to help them live longer from 1 December 2019. More >>
21,000 to benefit from Mirena and Jaydess
Monday, 14 October 2019, 9:27 am | PHARMAC
PHARMAC is widening funded access to Mirena, as well as listing a new long-acting reversible contraceptive option, Jaydess, which will benefit around 21,000 New Zealand women. More >>
PHARMAC signs bundle deal for more cancer medicines
Monday, 7 October 2019, 1:41 pm | PHARMAC
420 New Zealanders with lung cancer, breast cancer, multiple sclerosis and respiratory disease will benefit each year from a bundle deal PHARMAC has finalised with a medicine supplier. More >>
